Thrombospondin (TSP) cDNA clones were isolated from a human fibroblast cDNA library by screening with degenerate synthetic oligodeoxynucleotides. The Thrombospondin (TSP) is a trimeric glycoprotein composed of identical subunits ofMr 180,000, which are disulfide-linked (1, 2). TSP was described originally as a platelet a-granule component, which is released upon platelet activation and associates with the platelet membrane in the presence of divalent cations (3). A role for TSP in platelet aggregation recently has been established by using both polyclonal (4, 5) and monoclonal (6) antibodies directed against TSP that inhibit secretion-dependent platelet aggregation. TSP is not unique to a granules of the platelet. It is synthesized, secreted, and incorporated into the extracellular matrix by a variety of cells including endothelial cells, fibroblasts, smooth muscle cells, and type II pneumocytes (7-9). Like other large matrix glycoproteins such as fibronectin, laminin, and von Willebrand factor, TSP is composed of discrete protease-resistant domains that mediate some of the binding functions of the intact molecule (2, 10). TSP has been shown to bind heparin (2, 11), sulfatides (12), fibrinogen (10, 13), fibronectin (14), plasminogen (15), and type V collagen (16), and domains of TSP representing some of these binding activities have been isolated and characterized (2, 5, 16) .
ABSTRACT
Thrombospondin (TSP) cDNA clones were isolated from a human fibroblast cDNA library by screening with degenerate synthetic oligodeoxynucleotides. The probes were designed based on the sequences of peptides isolated from tryptic digests of TSP. The largest clone identified contains an open reading frame that encodes the amino-terminal heparin binding domain of TSP and part of the immediately adjacent collagen binding domain, a region of TSP that includes the site of disulfide crosslinking responsible for trimer formation. In addition to the known amino-terminal sequence of mature TSP (which is identical to that of the heparin binding domain) and that of the collagen binding domain, the open reading frame predicts the amino acid sequences of four tryptic peptides including the one from which the probe sequences were derived. The sequence of the mature protein is preceded by an unusual signal peptide sequence of 18 residues. The heparin binding domain contains 240 amino acids including only one intradomain disulfide bond. In contrast, 80 residues beyond the start of the collagen binding domain, a cluster of 10 cysteine residues occurs within 40 amino acids corresponding to the point of interchain disulfide crosslinking in the TSP trimer.
RNA blot analysis indicates a TSP mRNA size of %8 kilobases and Southern blots are consistent with a single gene encoding TSP.
Thrombospondin (TSP) is a trimeric glycoprotein composed of identical subunits ofMr 180,000, which are disulfide-linked (1, 2) . TSP was described originally as a platelet a-granule component, which is released upon platelet activation and associates with the platelet membrane in the presence of divalent cations (3) . A role for TSP in platelet aggregation recently has been established by using both polyclonal (4, 5) and monoclonal (6) antibodies directed against TSP that inhibit secretion-dependent platelet aggregation. TSP is not unique to a granules of the platelet. It is synthesized, secreted, and incorporated into the extracellular matrix by a variety of cells including endothelial cells, fibroblasts, smooth muscle cells, and type II pneumocytes (7) (8) (9) . Like other large matrix glycoproteins such as fibronectin, laminin, and von Willebrand factor, TSP is composed of discrete protease-resistant domains that mediate some of the binding functions of the intact molecule (2, 10) . TSP has been shown to bind heparin (2, 11) , sulfatides (12), fibrinogen (10, 13) , fibronectin (14) , plasminogen (15) , and type V collagen (16) , and domains of TSP representing some of these binding activities have been isolated and characterized (2, 5, 16) .
Using a panel of monoclonal antibodies directed against identified domains of TSP in conjunction with automated microsequencing of these domains (17), we have derived a model for the structure of the TSP subunit as shown in Fig.   1 . The heparin binding domain of TSP has been identified by heparin-Sepharose affinity chromatography of TSP peptides generated by digestion with thermolysin (2), plasmin (18) , or chymotrypsin (19) . The isolated domain is a monomeric peptide of Mr =25,000 (2, 11) . We (2) and others (11, 19) have shown that the amino-terminal sequence of the heparin binding domain is identical to that of the intact TSP peptide chain of Mr 180,000 (Fig. 1) . The heparin binding function of TSP may be of physiological importance since both the hemagglutinating activity of TSP and its ability to agglutinate fixed activated platelets are inhibited by heparin (20, 21) . A polyclonal antiserum directed against this domain has been reported to inhibit platelet aggregation (4) , and the specific binding of TSP to sulfatides appears to be mediated by the heparin binding domain (12) .
Adjacent to the heparin binding domain of TSP lies the Mr 70,000 collagen binding domain. This domain, isolated as a trimer without reduction, contains the interchain disulfide bridges (18) . With electron microscopy (17) , it is seen as a rod-like structure in contrast to the globular heparin binding domain, and it serves as a connecting link between the NH2-terminal globular Mr 25,000 heparin binding domain and the larger COOH-terminal globular domain ofMr 70,000 (Fig.  1) . The COOH-terminal domain appears to contain binding sites for calcium (22) , fibrinogen (10) , and perhaps other proteins important in platelet aggregation (5, 17) .
To define further the structure of TSP, we have isolated cDNA clones encoding this molecule. We report here the nucleotide sequence derived from a 1.9-kilobase (kb) TSP cDNA that specifies the entire heparin binding domain and part ofthe type V collagen binding domain. The latter region appears to include the site of interchain disulfide crosslinking. (34) .
MATERIALS AND METHODS
Genomic DNA Restriction Analysis. High molecular weight DNA was prepared from nuclei of peripheral blood leuko-
RNA Isolation and Library Construction. The normal human fibroblast cell line JY10 (established at Washington University School of Medicine and a gift ofJoseph Yang) was grown in Dulbecco's modified Eagle's medium supplemented with 10%o fetal calf serum, and penicillin and streptomycin at 100 ,ug/ml. Polyadenylylated RNA was extracted by using guanidinium thiocyanate and CsCl density centrifugation (24) and oligo(dT) cellulose chromatography (25) . Synthesis of the first and second cDNA strands followed standard protocols (26, 27) . After addition of homopoly(G) tails (28) (35) . Digestion of 10 jig of DNA with the restriction endonucleases at 3 units/,ug was performed according to the manufacturer's specifications. The samples were subjected to electrophoresis through 0.8% horizontal agarose slab gels in 50 mM Tris HCl/12 mM Na acetate/1 mM EDTA, pH 8, for 15 hr and transferred to nitrocellulose filters (36) . Prehybridization and hybridization of the DNA containing filters and the subsequent steps were performed as described (37 positive recombinants were identified that hybridized to both sets of probes and cross-hybridized to each other. Plasmid DNA prepared from these clones had cDNA inserts ranging from 850 to 1890 bp. The 1890-bp cDNA was further characterized by restriction enzyme and nucleotide sequence analysis.
Nucleotide Sequence Analysis. Fig. 2 is a restriction map of the 1.9-kb TSP cDNA and depicts the nucleotide sequencing strategy used. The DNA sequence of the first 1250 nucleotides is shown in Fig. 3 . Translation of this sequence revealed an open reading frame starting at the 5' end of the clone. The first ATG (nucleotides 121-123) encountered proceeding from the 5' end of the cDNA is embedded in a perfect match with the consensus sequence suggested by Kozak (40) for eukaryotic initiator ATGs (boxed nucleotides in Fig. 3 ). The methionine specified by this first ATG immediately precedes a hydrophobic putative signal peptide sequence of 18 residues (dashed underlining in Fig. 3 ). This region is immediately followed by the NH2-terminal sequence of mature TSP, which is known for 25 residues, beginning at nucleotide 175 (boxed in Fig. 3 ). Further downstream in the same reading frame are the sequences of three of the tryptic peptides (underlined), which were determined during this study, including the one from which the oligonucleotides used for library screening were derived (double underlining). Continuing in this reading frame, the 241st amino acid residue from the start of the mature protein begins the 11-residue amino acid sequence (boxed in Fig. 3 iATkGC.TGGCCTGGGGACTAGGCGTCCTGTTCCTGATGCATGTGTGTGGCACCAACCGCATTCCAGTGCGGAGACACAGCGTGTTTGACATCTTTGAACTCACCGGGGCCGCC is boxed, as is the 11-residue amino acid sequence found at the beginning of the M, 70,000 collagen binding domain (see Fig. 1 ). Also boxed are the two asparagine residues (N), which are potential glycosylation sites (Asn-X-Thr/Ser). Tryptic peptides whose sequences were determined as part of this study are underlined; the peptide used to direct the synthesis of the degenerate oligonucleotide probes is double underlined. Cysteine residues (C) are circled. The first 8 nucleotides are presumably part of the deoxycytidine tail added to the vector prior to cloning. Amino acids are designated by the single-letter code.
Biochemistry: Dixit et A Proc. Nati. Acad. Sci. USA 83 (1986) another of the tryptic peptides sequenced for this work. Beyond nucleotide 1250, the sequence has not been confirmed by either amino acid sequence data or by isolation of confirmatory cDNA clones. Thus, in all, this reading frame predicts six bona fide TSP sequences, two of which occur at known sites in the TSP peptide chain. The amino acid composition predicted from the cDNA for the heparin binding region of TSP (amino acids 1-240) is in excellent agreement with-the amino acid compositions of the heparin binding domain published by us (2) and others (18) . In the earlier studies, it was noted that this region of TSP is quite low in cysteine (0-2 residues). The sequence in Fig. 3 includes only two cysteine residues prior to the beginning of the collagen binding domain, which must form a single disulfide bond within the heparin binding domain. When the heparin binding domain is cleaved from TSP with a variety of proteases, it is monomeric; hence, no disulfide bonds link it to the rest of the peptide chain (2, 18, 19) . However, the mobility of the peptide on NaDodSO4 gels is decreased somewhat upon reduction (18) , suggesting the presence of an intrapeptide disulfide bond, as predicted by the sequence reported here.
In contrast to the low cysteine content of the heparin binding domain, there exists at a position 80 amino acids beyond the start of the collagen binding region a cluster of 10 cysteine residues distributed within a 40-residue span of the TSP sequence (318-379). Interestingly, this point closely corresponds to the region of predicted interchain disulfide crosslinks that stabilize the trimeric structure of TSP. Two potential glycosylation sites are contained within this portion of TSP [boxed asparagines (Ns) in Fig. 3 ]. However, it is not known if these are in fact glycosylated in the mature TSP structure.
RNA Hybridization Studies. A mixture of labeled restriction fragments from the 3' and 5' ends of the TSP cDNA hybridize to an RNA transcript in JY10 cells of =8.0 kb long (Fig. 4A) . No TSP mRNA is observed in this experiment in (10 ,g ) was denatured with glyoxal, electrophoresed, and transferred to nitrocellulose as described. The filter was hybridized to 32P-labeled TSP cDNA probes consisting of the 5' and 3' Pvu II restriction fragments (see Fig. 2 human kidney RNA, in RNA from the well-differentiated human hepatoma cell line Hep-G2, or in RNA from a B-lymphocyte cell line (Fig. 4A) . No discrete bands of smaller size are seen in any of these cell types.
DNA Hybridization Studies. Fig. 4B illustrates hybridization of 32P-labeled TSP cDNA to human genomic DNA. The finding that only one or two discrete restriction fragments of DNA from four different enzyme digests hybridize to the TSP cDNA probe is consistent with the existence of a single gene for TSP. Confirmation, however, must await more detailed Southern blot analyses using a full-length TSP cDNA.
DISCUSSION
In this report, we describe the characterization of a cDNA encoding the amino-terminal 376 residues ofthe peptide chain of human TSP. The clone was isolated from a human fibroblast library by using synthetic degenerate oligonucleotide probes. The authenticity of the clone is established by the fact that not only does it predict the amino-terminal sequence of mature TSP but it also predicts, in frame, the previously reported amino-terminal sequence of the Mr 70,000 chymotryptic fragment of TSP, which represents the collagen binding domain (17) . The cDNA further predicts the sequence of four other tryptic peptides determined during this study, one of which was used to direct the synthesis of the oligonucleotide probes.
The heparin binding domain of TSP is a compact globular region that is extremely protease resistant (17, 18 (45) but not an attachment factor for these or other cell types. A further functional distinction is that the heparin binding domains of both TSP (12) and laminin (46) (47) .
The inability to detect TSP mRNA transcripts in the kidney and in the Hep-G2 and B cell lines may reflect a lack of sensitivity of the techniques used in this study. Such transcripts should be found in the vascular endothelium of kidney (7) and may be detectable by other methods such as S1 nuclease protection analysis. The finding of a single gene for TSP should be considered preliminary until a full-length cDNA is available for genomic Southern blotting.
The characterization of a cDNA for TSP is the first step in delineating the entire amino acid sequence of the protein. This information is needed to define precisely the structural model for TSP, which in turn will allow detailed examination of the structure-function relationships of this protein, which has an important role in platelet aggregation as well as in the extracellular matrix.
